MET and esophageal squamous cell carcinoma: The results of our in vitro studies demonstrated the important role of HGF as a c-Met activator and the efficacy of the c-Met small-molecule inhibitor PF-2341066, especially in KYSE170 cells with the highest c-Met mRNA expression among the three ESCC cell lines tested.